DRAP Guidelines on Recalls of Defective Products: Procedure
The new article describes in detail the recall procedure to be followed when removing defective products from the market to ensure the safety of patients.
The new article describes in detail the recall procedure to be followed when removing defective products from the market to ensure the safety of patients.
The new article provides an overview of the critical responsibilities of the parties involved in recalls associated with therapeutic products, as well as additional communication details to ensure the vitally important safety information is duly delivered to the affected parties.
The new article highlights certain specific aspects related to the recalls the parties responsible for medical devices should initiate once it is identified that such products may pose risks to public health.
The new article highlights the aspects of clinical research concerning the products intended to be marketed and used in Pakistan.
The article describes in detail the transitional arrangements associated with the recent regulatory changes in the European Union.
The article provides an overview of the applicable importation requirements in Guatemala.